What is the preferred imaging test, Computed Tomography Pulmonary Angiography (CTPA) or Ventilation-Perfusion scan (VQ scan), for diagnosing pulmonary embolism in an 8-week pregnant patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

VQ Scan is Preferred Over CTPA for Suspected Pulmonary Embolism in an 8-Week Pregnant Patient

For an 8-week pregnant patient with suspected pulmonary embolism (PE), a Ventilation-Perfusion (VQ) scan is the preferred imaging test over Computed Tomography Pulmonary Angiography (CTPA), particularly if the chest X-ray is normal. 1

Diagnostic Algorithm for PE in Pregnancy

  1. Initial Assessment:

    • Chest X-ray (CXR) should be the first radiation-associated procedure 1
    • This helps triage between VQ scan and CTPA
  2. Based on CXR Results:

    • Normal CXR: Proceed with VQ scan (strong recommendation) 1
    • Abnormal CXR: Consider CTPA (weak recommendation) 1
  3. If VQ scan is non-diagnostic:

    • Proceed to CTPA rather than clinical management alone 1

Rationale for VQ Scan Preference

Radiation Exposure Considerations

  • Maternal Breast Radiation:

    • VQ scan: 0.28-0.37 mGy 2
    • CTPA: 44 mGy 2
    • This significant difference in breast radiation exposure is particularly important as it relates to future maternal breast cancer risk 1
  • Effective Dose:

    • VQ scan: 1.04-1.29 mSv 2
    • CTPA: 21 mSv 2
  • Fetal Radiation:

    • Both modalities deliver doses well below the threshold for fetal risk
    • VQ scan: 0.25-0.40 mGy 2
    • CTPA: 0.46 mGy 2

Diagnostic Performance

  • Both modalities have similar false-negative rates:

    • VQ scan: 0.5% (95% CI, 0.2%-1.3%) 1
    • CTPA: 0.4% (95% CI, 0.2%-1.3%) 1
  • Non-diagnostic rates in pregnancy:

    • VQ scan: 9.3% 3
    • CTPA: 9.3% 3
    • However, more recent data suggests higher non-diagnostic rates with CTPA in pregnancy 4

Important Clinical Considerations

  • PE is uncommon in pregnancy but is a leading cause of maternal mortality, accounting for 20% of maternal deaths in the US 1

  • The American Society of Hematology (2018) and American Thoracic Society/Society of Thoracic Radiology (2011) both recommend VQ scanning over CTPA when chest X-ray is normal 1

  • Low-dose perfusion scanning (LDQ) has shown excellent negative predictive value (100%) in pregnancy 3

  • The positive scan rate for PE in pregnancy is low (3.5%), highlighting the importance of appropriate patient selection for imaging 4

Pitfalls to Avoid

  1. Do not skip the chest X-ray: It's essential for determining the optimal subsequent imaging modality 1

  2. Do not use D-dimer to exclude PE in pregnancy: D-dimer levels naturally increase during pregnancy and have poor specificity 1

  3. Availability considerations: If VQ scanning is not readily available, CTPA is an acceptable alternative 1

  4. Do not assume CTPA is always superior: While CTPA is generally more sensitive for PE detection in non-pregnant patients, the radiation exposure considerations in pregnancy shift the risk-benefit balance toward VQ scanning when the chest X-ray is normal 1, 2

  5. Do not overlook alternative diagnoses: If the chest X-ray is abnormal, CTPA may be preferred as it can identify alternative causes of symptoms 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.